Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 550}, 'targetDuration': '90 Days', 'patientRegistry': True}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-09-25', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-10', 'completionDateStruct': {'date': '2024-12-15', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-10-07', 'studyFirstSubmitDate': '2023-08-31', 'studyFirstSubmitQcDate': '2023-08-31', 'lastUpdatePostDateStruct': {'date': '2023-10-10', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-09-08', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-09-15', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'mortality', 'timeFrame': '28 day'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['invasive aspergillus infection'], 'conditions': ['Invasive Aspergillosis']}, 'descriptionModule': {'briefSummary': 'To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.', 'detailedDescription': 'To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients diagosed as invasive aspergillosis', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Age\\>18 year-old\n* Diagosed as invasive aspergillus infection\n\nExclusion Criteria:\n\n* Pregnant'}, 'identificationModule': {'nctId': 'NCT06028451', 'briefTitle': 'ManagemEnt of Antifungal Drug in Invasive Aspergillosis:a Real-word Study', 'organization': {'class': 'OTHER', 'fullName': 'Southeast University, China'}, 'officialTitle': 'ManagemEnt of Antifungal Drug in Invasive Aspergillosis:a Real-word Study', 'orgStudyIdInfo': {'id': '2023ZDSYLL357-P01'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Survivors', 'description': 'Critically ill patients with invasive aspergillus infection who survived', 'interventionNames': ['Other: Record the information data']}, {'label': 'Nonsurvivors', 'description': 'Critically ill patients with invasive aspergillus infection who not survived', 'interventionNames': ['Other: Record the information data']}], 'interventions': [{'name': 'Record the information data', 'type': 'OTHER', 'description': 'Record the information data', 'armGroupLabels': ['Nonsurvivors', 'Survivors']}]}, 'contactsLocationsModule': {'locations': [{'zip': '210000', 'city': 'Nanjing', 'state': 'Jiangsu', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'Jingyuan Xu, M.D.', 'role': 'CONTACT', 'email': '1381417209@163.com', 'phone': '861381417209'}, {'name': 'Jingyuan Xu, M.D.', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Southeast University, Zhongda hospital', 'geoPoint': {'lat': 32.06167, 'lon': 118.77778}}], 'centralContacts': [{'name': 'Jingyuan Xu, M.D.', 'role': 'CONTACT', 'email': '13851417209@163.com', 'phone': '8613851417209'}, {'name': 'Jingyuan Xu, M.D.', 'role': 'CONTACT', 'email': '13851417209@163.com', 'phone': '13851417209'}], 'overallOfficials': [{'name': 'Jingyuan Xu, M.D.', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Southeast University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Southeast University, China', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Jingyuan,Xu', 'investigatorAffiliation': 'Southeast University, China'}}}}